INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
Tempus One

The first generative AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.

Try Tempus One If you do not have a Hub account, create one now.
Tempus One

Smart technology to assist in clinical treatment decisions—anytime, anywhere.

Quick access to patient order status and reports.

Get report information on actionable biomarkers and receive updates on the status of a patient’s report.

Rapid filtering of patient incidence by alteration, gene or diagnoses.

Review relevant cohorts of your patients for additional insight into decision making.

Request test add-ons for an order.

Add an algorithmic test like HRD, an IHC test, or cancel an existing order.

Streamlined access to evidence-based therapy information.

Access MSK’s OncoKB™ for the latest data on treatment strategies.

Understand potential adverse events to therapies.

Dive deeper into notable adverse events that may be relevant to your patient.

Up-to-date clinical trial information.

Search for clinical trials based on specific patient enrollment criteria.

Comprehensive exploration of medical research.

Locate relevant articles and publications with PubMed® search.

EXPLORE TEMPUS ONE

Don't take our word for it. Hear how others are using Tempus One.

  • Asking Tempus One a verbal question about the status of a test, results for a specific patient, or to look at trends across several patients is super intuitive and easy to use.  It has helped with efficiently getting the real-time NGS answers I need in the clinic without the burden of digging through the chart or individual report.

    image description
    Thomas George, MD, FACP, University of Florida Cancer Center
  • Tempus One demonstrates the power of assistive technologies by simplifying the often complex process of ordering, obtaining, and interpreting genomic testing. The ability to have a voice assistant augment our efforts in delivering precision oncology allows us to unlock the power of artificial intelligence for direct clinical benefit for our patients.

    image description
    Sandip Patel, MD, UC San Diego Health
  • Tempus One is a great platform that allows me to personalize my patients care — in my office, in the community setting, at my fingertips — and to me, that is the future of oncology.

    image description
    Kamal Sharma, DO, The Oncology Institute, Lakeland, FL

Partnering with Tempus is investing in the future

Every new test and data point strengthens our algorithms, predictions, and recommendations to improve treatment options for future patients.